Cavalieri S, Snyder I
Infect Immun. 1982; 36(2):455-61.
PMID: 7044971
PMC: 351249.
DOI: 10.1128/iai.36.2.455-461.1982.
Waalwijk C, van den Bosch J, MACLAREN D, de Graaff J
Infect Immun. 1982; 35(1):32-7.
PMID: 7033139
PMC: 350991.
DOI: 10.1128/iai.35.1.32-37.1982.
Berger H, Hacker J, Juarez A, Hughes C, Goebel W
J Bacteriol. 1982; 152(3):1241-7.
PMID: 6754701
PMC: 221631.
DOI: 10.1128/jb.152.3.1241-1247.1982.
Cavalieri S, Snyder I
Infect Immun. 1982; 37(3):966-74.
PMID: 6752033
PMC: 347633.
DOI: 10.1128/iai.37.3.966-974.1982.
Cavalieri S, Bohach G, Snyder I
Microbiol Rev. 1984; 48(4):326-43.
PMID: 6394977
PMC: 373222.
DOI: 10.1128/mr.48.4.326-343.1984.
In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes.
Gadeberg O, ORSKOV I
Infect Immun. 1984; 45(1):255-60.
PMID: 6376357
PMC: 263309.
DOI: 10.1128/iai.45.1.255-260.1984.
Effect of the estrous cycle on uterine infection induced by Escherichia coli.
Nishikawa Y, Baba T, Imori T
Infect Immun. 1984; 43(2):678-83.
PMID: 6363298
PMC: 264353.
DOI: 10.1128/iai.43.2.678-683.1984.
Cloned hemolysin genes from Escherichia coli that cause urinary tract infection determine different levels of toxicity in mice.
Hacker J, Hughes C, Hof H, Goebel W
Infect Immun. 1983; 42(1):57-63.
PMID: 6352503
PMC: 264523.
DOI: 10.1128/iai.42.1.57-63.1983.
Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli.
Hughes C, Hacker J, Roberts A, Goebel W
Infect Immun. 1983; 39(2):546-51.
PMID: 6339382
PMC: 347985.
DOI: 10.1128/iai.39.2.546-551.1983.
Inactivation of haemolysin production in Escherichia coli by transposon insertion results in loss of virulence.
Waalwijk C, de Graaff J
Antonie Van Leeuwenhoek. 1983; 49(1):23-30.
PMID: 6311093
DOI: 10.1007/BF00457876.
Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli.
Hugo F, Arvand M, Reichwein J, Mackman N, Holland I, Bhakdi S
J Clin Microbiol. 1987; 25(1):26-30.
PMID: 3539994
PMC: 265810.
DOI: 10.1128/jcm.25.1.26-30.1987.
Experimental haematogenous pyelonephritis in mice with uropathogenic, enteropathogenic and enterotoxigenic Escherichia coli.
Kakar K, Sharma S, Asnani P, Banerjee C, Sharma B
Antonie Van Leeuwenhoek. 1986; 52(2):153-61.
PMID: 3524448
DOI: 10.1007/BF00429319.
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.
Bhakdi S, Mackman N, Nicaud J, Holland I
Infect Immun. 1986; 52(1):63-9.
PMID: 3514465
PMC: 262198.
DOI: 10.1128/iai.52.1.63-69.1986.
The hemolysin of Escherichia coli.
Bhakdi S, Mackman N, Menestrina G, Gray L, Hugo F, Seeger W
Eur J Epidemiol. 1988; 4(2):135-43.
PMID: 3042445
DOI: 10.1007/BF00144740.
Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.
Seeger W, Walter H, Suttorp N, Muhly M, Bhakdi S
J Clin Invest. 1989; 84(1):220-7.
PMID: 2500455
PMC: 303973.
DOI: 10.1172/JCI114144.
Immune response to Escherichia coli alpha-hemolysin in patients.
Seetharama S, Cavalieri S, Snyder I
J Clin Microbiol. 1988; 26(5):850-6.
PMID: 2454938
PMC: 266473.
DOI: 10.1128/jcm.26.5.850-856.1988.
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells.
Scheffer J, Konig W, Hacker J, Goebel W
Infect Immun. 1985; 50(1):271-8.
PMID: 2412960
PMC: 262167.
DOI: 10.1128/iai.50.1.271-278.1985.
Virulence factors in Escherichia coli urinary tract infection.
Johnson J
Clin Microbiol Rev. 1991; 4(1):80-128.
PMID: 1672263
PMC: 358180.
DOI: 10.1128/CMR.4.1.80.
Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice.
van den Bosch J, de Graaff J, MACLAREN D
Infect Immun. 1979; 25(1):68-74.
PMID: 383622
PMC: 414422.
DOI: 10.1128/iai.25.1.68-74.1979.
